Australian Stock News

Objective (ASX:OCL) has drawn fresh attention after its board approved an on market buyback of up to 9,590,176 shares, or 10% of issued capital, running through to February 5, 2027. See our latest analysis for Objective. That buyback decision comes after a stretch of weaker momentum, with the share price at A$14.63 and a 90 day share price return showing a decline of 21.05%, while the 5 year total shareholder return of 13.72% remains in positive territory. If this kind of capital management...

If you are wondering whether Perseus Mining is still priced sensibly after a strong run, this article will walk through what the current share price might be implying about its value. The stock recently closed at A$5.69, after a 100.2% return over the past year, a 0.9% gain year to date, a 0.9% decline over 30 days, and an 11.5% decline over the last week, which may have caught your attention. Recent market interest has been shaped by ongoing sector sentiment around gold miners and how...

Why the latest RBA move matters for Commonwealth Bank of Australia (ASX:CBA) The Reserve Bank of Australia’s 25 basis point cash rate hike is back in focus for Commonwealth Bank of Australia (ASX:CBA). Investors are weighing margin effects against upcoming half year results and recent one off adjustments. See our latest analysis for Commonwealth Bank of Australia. The share price has reacted quickly to the rate decision, with a 1 day share price return of 2.60% and a 7 day share price return...

Recent ASX technical scans flagged Technology One (ASX:TNE) for a downtrend and excess supply, prompting closer attention from traders and long term holders who are watching for any shift in price momentum. See our latest analysis for Technology One. At a latest share price of A$22.65, Technology One has seen its short term share price return weaken, with a 1 day move of 10.47% and a 90 day share price return of 37.89%, while longer term total shareholder returns over three and five years, at...

Westpac Banking Corporation recently saw its shares move in response to the Reserve Bank of Australia’s 25 basis point cash rate increase to 3.85%, which has direct implications for bank margins, funding costs and mortgage repricing. With Westpac’s first-quarter update on 13 February set to detail changes in home-loan growth, deposit mix and credit quality, investors are focused on how the higher-rate backdrop is feeding through to the bank’s underlying business trends. We’ll now examine...

In early February 2026, Ansell Limited launched the TouchNTuff 93-800, a disposable glove that offers at least 15 minutes of acetone resistance, around fifteen times longer than standard nitrile gloves, using a multi-layer design that combines neoprene, nitrile and natural rubber latex for high chemical, abrasion and cut protection. Beyond safety, the glove’s ergonomic construction, high-visibility orange color and more than 60% bio-based carbon content highlight Ansell’s push to pair...

Why 4DMedical Shares Are Back in Focus 4DMedical (ASX:4DX) is back on investor radars after expanding its partnership with University of Chicago Medicine to include commercial deployment of its CT:VQ respiratory imaging technology. See our latest analysis for 4DMedical. The commercial CT:VQ rollout headlines a period where 4DMedical’s 90 day share price return of about 131% contrasts sharply with a 26% decline year to date, while its one year total shareholder return is very large at over...

Reliance Worldwide Corporation Limited has opened its new Training Center in Atlanta, a facility designed to showcase the company’s history, innovation, and family of plumbing brands while serving as an immersive learning space. The center doubles as a destination for aspiring plumbing professionals, underlining Reliance Worldwide’s focus on workforce development and smarter, more reliable plumbing solutions. We’ll now explore how this new Atlanta Training Center, with its emphasis on future...

As we enter February 2026, global markets are navigating a complex landscape marked by steady interest rates from the Federal Reserve and mixed performances across major indices, with small- and mid-cap stocks underperforming their larger counterparts. Amid these conditions, identifying promising small-cap opportunities often involves looking for companies that can thrive despite broader economic challenges and exhibit signs of potential growth through strategic insider activity.

GrainCorp (ASX:GNC) has come under pressure after issuing FY26 guidance that points to significantly lower underlying EBITDA and net profit, as global grain oversupply and multi year low export margins squeeze returns. See our latest analysis for GrainCorp. The FY26 update has come after a tough stretch for the shares, with a 1 day share price return of 3.02% decline and a 7 day share price return of 20.14% decline, while the 1 year total shareholder return of 16.60% decline contrasts with a...

Xero recently filed to list new shares issued under employee awards and options, while investors reassessed the company’s large Melio acquisition and its integration progress. At the same time, FundingSearch.com’s launch with direct integration into Xero’s platform highlights how third-party fintechs increasingly rely on Xero’s real-time accounting data to power SME lending decisions. We’ll now examine how concerns about the Melio acquisition and its integration could influence Xero’s...

Why the WinDC partnership matters for Megaport (ASX:MP1) WinDC’s new partnership with Megaport (ASX:MP1) links modular, renewable-powered AI compute sites directly into Megaport’s Network as a Service platform. This creates a fresh use case for its global connectivity offering. This arrangement gives Megaport exposure to a new category of Australian AI infrastructure that aims to use renewable energy more efficiently, while offering WinDC customers private, low-latency links to cloud...

Neuren Pharmaceuticals’ partner Acadia Pharmaceuticals recently received a negative trend vote from the European Medicines Agency’s Committee for Medicinal Products for Human Use on trofinetide’s marketing authorisation application for Rett syndrome in Europe, and Acadia plans to request a re-examination of the decision. This setback highlights how regulatory assessments can differ across regions even for a rare-disease therapy already approved in the US, Canada and Israel, adding...

In recent weeks, analysts at UBS and Macquarie reiterated positive ratings on Bellevue Gold Limited, highlighting the miner’s latest quarterly update and operational progress. Despite reporting a net loss for the period, Bellevue Gold’s higher quarterly revenue compared with the previous year has drawn increased attention to its underlying growth profile and project momentum. Next, we’ll examine how this combination of upbeat analyst sentiment and higher quarterly revenue shapes Bellevue...

Fresh production test results put Vulcan Energy Resources (ASX:VUL) in focus Vulcan Energy Resources (ASX:VUL) has drawn attention after reporting successful production test results from its first new Lionheart well in Germany, confirming strong deliverability that supports its Phase One lithium project plans. See our latest analysis for Vulcan Energy Resources. Despite the positive Lionheart test update, Vulcan Energy Resources’ recent share price momentum has been weak, with a 7 day share...

The Australian market is facing a cautious start to the day following the Reserve Bank's recent rate hike, with ASX 200 futures indicating a potential dip amid broader global economic concerns. In this climate of uncertainty, investors often turn their attention to smaller or newer companies that can offer unique opportunities for growth and value. Although the term "penny stocks" might seem outdated, these stocks still represent an intriguing segment of the market where financial strength...

What Atlas Arteria’s latest revenue update means for shareholders Atlas Arteria (ASX:ALX) has reported Q4 and full-year 2025 toll revenue growth of about 9.5%, supported by higher traffic on key French and US roads alongside recent toll increases and steady economic conditions. See our latest analysis for Atlas Arteria. Despite the solid toll revenue update, Atlas Arteria’s recent 30 day share price return of 1.23% and year to date share price return of 1.23% suggest momentum has softened...

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...

The recent 10% drop in Felix Group Holdings Ltd's ( ASX:FLX ) stock could come as a blow to insiders who purchased...

When close to half the companies operating in the Professional Services industry in Australia have price-to-sales...

Iress recently appointed Laura King to the newly created role of Head of Operations and Relationship Management, uniting its Operations and Relationship Management teams to deliver more coordinated support for Xplan users and enhance its UK service model. This move caps an 18‑month programme of operational changes that have already improved customer satisfaction, engagement and retention among UK wealth management clients. With this leadership appointment aiming to elevate service excellence...

Insiders who bought Alicanto Minerals Limited ( ASX:AQI ) stock in the last 12 months were richly rewarded last week...

Key Insights Using the 2 Stage Free Cash Flow to Equity, Kogan.com fair value estimate is AU$6.91 Current share price...

The recent price decline of 15% in AdNeo Limited's ( ASX:AD1 ) stock may have disappointed insiders who bought...